Delivery Order SPE2DB25D3006-SPE2DB25FXJUN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,759.58 to AmerisourceBergen Drug Corp for the supply of ADDYI 100 mg tablets in quantities of 30 units. This non-set-aside, competitively awarded contract was executed on July 10, 2025, with an ultimate completion date of July 11, 2025, and utilizes firm fixed pricing. The awardee, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,410.28 to AmerisourceBergen Drug Corp for ADDYI 100 mg tablets (30-count units) on September 5, 2025, with an ultimate completion date of September 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $35,858.57 to AmerisourceBergen Drug Corp for supply of ADDYI 100 mg tablets in quantities of 30-count units. The contract is a firm fixed price delivery order with an ultimate completion date of September 26, 2025, and was awarded on September 25, 2025, with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a firm fixed-price delivery order valued at $7,344.91 for ADDYI 100 mg tablets (30-count units) on July 9, 2025, with an ultimate completion date of July 10, 2025. This non-set-aside contract represents a competitively awarded procurement supporting federal medical supply needs. The place of performance is located in Conshohocken, Pennsylvania, which is also the headquarters location of the prime contractor. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ADDYI 100 mg tablets (flibanserin) on August 21, 2025, with a ceiling value of $7,861.63 and an ultimate completion date of August 22, 2025. This non-set-aside, firm fixed-price delivery order represents a routine pharmaceutical procurement executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- This delivery order, valued at $4,281.88, was awarded on July 18, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of ADDYI (flibanserind) 100 mg tablets in quantities of 30 units. The contract employs firm fixed pricing with no set-aside designation, indicating competitive procurement. Performance will be fulfilled from the contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of July 21, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for the supply of ADDYI 100 mg tablets in quantities of 30 tablets per unit, with a ceiling value of $31,068.83. This competitive award utilizes firm fixed pricing and is structured as a delivery order without set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters, with an ultimate completion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $15,454.99 on September 16, 2025, for the supply of ADDYI 100 mg tablets in packages of 30. This non-set-aside, competitively awarded delivery order carries a firm fixed price structure and is scheduled for completion by September 17, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters as one of the nation's...
- The Defense Logistics Agency awarded a delivery order valued at $1,935.74 to AmerisourceBergen Drug Corp for ADDYI (flibansergin) 100 mg tablets in quantities of 30 units. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing work at its corporate office location. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $3,096.83 to AmerisourceBergen Drug Corp for 30 tablets of ADDYI 100 mg on September 18, 2025, with completion scheduled for September 19, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a...
- SPE2DB25D3006Indefinite Delivery Contract
- SPE2DB25D3006-SPE2DB25FXJUNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,217.96 to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of ADDYI 100 mg tablets in quantities of 30 units. This contract utilizes a firm fixed-price structure with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of July 15, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime contract vehicle designated SPE2DX and running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and other government healthcare entities. The company's extensive federal contracting portfolio demonstrates its capability to supply a comprehensive range of pharmaceutical products, including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This specific delivery order for ADDYI represents one component of the company's ongoing support to federal medical supply chains through its prime IDC vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.2k | 7/14/25 |